Dan Lemaitre, Chairman & CEO of Bluewind Medical will describe how he leads an innovative medical device company with operations in Park City and Isreal.  Bluewind uses novel technology to address medical conditions in totally non-intuative ways producing very effective results.  

Dan Lemaitre joined BlueWind Medical as Executive Chairman in September 2018 and serves as CEO since January 2020. Dan also serves on the board of Globus Medical (NYSE: GMED) one of the fastest-growing spinal companies with revenue of ~$700 million per annum. Previously, Dan was the CEO of CoreValve which launched the first commercial transcatheter aortic valve in Europe in 2007. Prior to joining CoreValve, Dan was a Senior Vice President at Medtronic where he headed up strategic planning and corporate development. Earlier in his career, Dan spent 28 years in the medical device field as an investment analyst.